Back
Prothena Corp PLC Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
47
PRTA
Prothena Corp PLC
Last Price:
20.65
Seasonality Move:
17.79%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Sell
47
Prothena Corp PLC (PRTA)
is a Sell
Is Prothena Corp PLC a Buy, Sell or Hold?
- The current Prothena Corp PLC [PRTA] share price is $20.53. The Score for PRTA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PRTA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $247.00. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRTA Stock Price Chart
What is Prothena Corp PLC's stock price today?
-
The Prothena Corp PLC share price today is $20.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRTA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $247.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
PRTA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.3 | Sell |
Relative Strength Index (14 RSI): | 46.94 | Sell |
Chaikin Money Flow: | 251347 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20 - 21.66) | Sell |
Bollinger Bands (100): | (20.71 - 26.85) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.83 | Buy |
Relative Strength Index (14 RSI): | 90.67 | Buy |
Chaikin Money Flow: | -365678 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.21 - 198.95) | Buy |
Bollinger Bands (100): | (137.63 - 173.99) | Buy |
PRTA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.49 | Buy |
20-day SMA: | 20.96 | Sell |
50-day SMA: | 21.26 | Sell |
200-day SMA: | 31.49 | Sell |
8-day EMA: | 20.62 | Sell |
20-day EMA: | 20.86 | Sell |
50-day EMA: | 21.83 | Sell |
200-day EMA: | 31.23 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 198.72 | Buy |
20-day SMA: | 171.59 | Buy |
50-day SMA: | 157.67 | Buy |
200-day SMA: | 165.81 | Buy |
8-day EMA: | 210.85 | Buy |
20-day EMA: | 183.04 | Buy |
50-day EMA: | 165.87 | Buy |
200-day EMA: | 167.34 | Buy |
Prothena Corp PLC Earnings Growth & PRTA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.85 per share, a decrease next quarter of $0.32 per share, a decrease this year of $1.84 per share, and an increase next year of $0.54 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Prothena Corp PLC Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |